Cargando…

Validation of DREADD agonists and administration route in a murine model of sleep enhancement

BACKGROUND: Chemogenetics is a powerful tool to study the role of specific neuronal populations in physiology and diseases. Of particular interest, in mice, acute and specific activation of parafacial zone (PZ) GABAergic neurons expressing the Designer Receptors Activated by Designer Drugs (DREADD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrari, Loris L., Ogbeide-Latario, Oghomwen E., Gompf, Heinrich S., Anaclet, Christelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228294/ https://www.ncbi.nlm.nih.gov/pubmed/35914577 http://dx.doi.org/10.1016/j.jneumeth.2022.109679

Ejemplares similares

Two novel mouse models of slow-wave-sleep enhancement in aging and Alzheimer’s disease
por: Ogbeide-Latario, Oghomwen E, et al.
Publicado: (2022)

Differential Role of Pontomedullary Glutamatergic Neuronal Populations in Sleep-Wake Control
por: Erickson, Evelyn T. M., et al.
Publicado: (2019)

DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs in Vitro and in Vivo
por: Thompson, Karen J., et al.
Publicado: (2018)

The Use of DREADDs to Deconstruct Behavior
por: Whissell, Paul D., et al.
Publicado: (2016)

Eye-Drops for Activation of DREADDs
por: Keenan, William T., et al.
Publicado: (2017)

Using DREADDs to Isolate Internal Clocks
por: Farrell, Martilias S.
Publicado: (2011)

Chronic DREADD Isn’t As Bad As It Sounds
por: Hyder, Safwan K., et al.
Publicado: (2020)

GABAergic parafacial zone is a medullary slow–wave–sleep promoting center
por: Anaclet, Christelle, et al.
Publicado: (2014)

DREADD: A Chemogenetic GPCR Signaling Platform
por: Zhu, Hu, et al.
Publicado: (2014)

From DREADD to Treatment in Temporal Lobe Epilepsy
por: Wong, Jennifer C., et al.
Publicado: (2019)

DREADDs in Epilepsy Research: Network-Based Review
por: Mueller, John-Sebastian, et al.
Publicado: (2022)

The DREADDful Hurdles and Opportunities of the Chronic Chemogenetic Toolbox
por: Claes, Marie, et al.
Publicado: (2022)

Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics
por: Weston, Mikail, et al.
Publicado: (2019)

Using Inhibitory DREADDs to Silence LC Neurons in Monkeys
por: Perez, Pauline, et al.
Publicado: (2022)

The Effect of DREADD Activation of Leptin Receptor Positive Neurons in the Nucleus of the Solitary Tract on Sleep Disordered Breathing
por: Amorim, Mateus R., et al.
Publicado: (2021)

Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments
por: MacLaren, Duncan A. A., et al.
Publicado: (2016)

A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition
por: Lawson, Kate A, et al.
Publicado: (2023)

High-potency ligands for DREADD imaging and activation in rodents and monkeys
por: Bonaventura, Jordi, et al.
Publicado: (2019)

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
por: Manvich, Daniel F., et al.
Publicado: (2018)

Activation of the Ventrolateral Preoptic Neurons Projecting to the Perifornical-Hypothalamic Area Promotes Sleep: DREADD Activation in Wild-Type Rats
por: Kostin, Andrey, et al.
Publicado: (2022)

Tracking the Time-Dependent Role of the Hippocampus in Memory Recall Using DREADDs
por: Varela, Carmen, et al.
Publicado: (2016)

Behavioral and slice electrophysiological assessment of DREADD ligand, deschloroclozapine (DCZ) in rats
por: Nentwig, Todd B., et al.
Publicado: (2022)

The use of chemogenetic actuator ligands in nonhuman primate DREADDs-fMRI
por: Cushnie, Adriana K., et al.
Publicado: (2022)

Deciphering and modulating G protein signalling in C. elegans using the DREADD technology
por: Prömel, Simone, et al.
Publicado: (2016)

Impact of administration route on nanocarrier biodistribution in a murine colitis model
por: Applegate, Catherine C., et al.
Publicado: (2022)

Brainstem Circuitry Regulating Phasic Activation of Trigeminal Motoneurons during REM Sleep
por: Anaclet, Christelle, et al.
Publicado: (2010)

Sleep-Waking Discharge of Ventral Tuberomammillary Neurons in Wild-Type and Histidine Decarboxylase Knock-Out Mice
por: Sakai, Kazuya, et al.
Publicado: (2010)

DREADD in Parvalbumin Interneurons of the Dentate Gyrus Modulates Anxiety, Social Interaction and Memory Extinction
por: Zou, D., et al.
Publicado: (2016)

Gs-DREADD Knock-In Mice for Tissue-Specific, Temporal Stimulation of Cyclic AMP Signaling
por: Akhmedov, Dmitry, et al.
Publicado: (2017)

Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens
por: Okada, N, et al.
Publicado: (2001)

Basal forebrain control of wakefulness and cortical rhythms
por: Anaclet, Christelle, et al.
Publicado: (2015)

Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis
por: Dragoljevic, Dragana, et al.
Publicado: (2023)

Combined Use of the Canine Adenovirus-2 and DREADD-Technology to Activate Specific Neural Pathways In Vivo
por: Boender, Arjen J., et al.
Publicado: (2014)

In vivo cardiopulmonary impact of skeletal M(3)Dq DREADD expression: a pilot study
por: Vincent, Sandra G., et al.
Publicado: (2021)

Comparative assessment of the effects of DREADDs and endogenously expressed GPCRs in hippocampal astrocytes on synaptic activity and memory
por: Lee, Sophie H., et al.
Publicado: (2023)

DREADD-mediated amygdala activation is sufficient to induce anxiety-like responses in young nonhuman primates
por: Mueller, Sascha A.L., et al.
Publicado: (2023)

DREADD-mediated amygdala activation is sufficient to induce anxiety-like responses in young nonhuman primates
por: Mueller, Sascha A.L., et al.
Publicado: (2023)

DREADD activation of the lateral orbitofrontal increases cocaine-taking and cocaine-seeking in male and female rats during intermittent access self-administration under risky conditions
por: Murphy, Zackari D., et al.
Publicado: (2023)

Route of Administration of the TLR9 Agonist CpG Critically Determines the Efficacy of Cancer Immunotherapy in Mice
por: Nierkens, Stefan, et al.
Publicado: (2009)

Sleep enhances knowledge of routes and regions in spatial environments
por: Noack, Hannes, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_or06klbjpv0hm5kb6cqjs29u1s